Media Database
>
Carolyn Johnson

Carolyn Johnson

Science Reporter at The Washington Post

Contact this person
Email address
c*****@*******.comGet email address
Influence score
55
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine
  • Science

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

washingtonpost.com

How mosquitoes use your body chemistry to pick you for their next meal - The Washington Post

To unravel how malaria-carrying mosquitoes sniff out their next juicy meal, scientists set up a screened-in outdoor laboratory in Zambia.
washingtonpost.com

How mosquitoes use your body chemistry to pick you for their next m...

To unravel how malaria-carrying mosquitoes sniff out their next juicy meal, scientists set up a screened-in outdoor laboratory in Zambia.
washingtonpost.com

The scientific reason kimchi is best made in earthenware onggi - Th...

For thousands of years, kimchi was fermented in earthenware vessels called “onggi.” Now, a pair of mechanical engineers have unraveled why.
washingtonpost.com

Surprising mummy ingredients found at ancient Egyptian workshop - T...

Scientists are unraveling the secrets of mummification – including the intriguing discovery that the practice may have been dependent on a global supply chain.
washingtonpost.com

Moderna says new booster increases protection from omicron ... - Th...

The shot increased the levels of antibodies that block the latest coronavirus subvariant.
washingtonpost.com

Pfizer says new booster shot increases omicron-fighting antibodies ...

Questions persist about the vaccine’s continued effectiveness against a swarm of later-generation versions of omicron.
washingtonpost.com

Omicron-based coronavirus booster shots will roll out this fall

The FDA announced that the fall shots would include a component from BA.4 and BA.5, the omicron subvariants gaining ground in the United States.
washingtonpost.com

Another rare virus puzzle: They got sick, got treated, got covid again

The rare cases aren’t severe but highlight the many questions that remain about the virus.
washingtonpost.com

Moderna says its coronavirus vaccine for young children is safe, bu...

Progress toward a pediatric vaccine has been impatiently awaited by parents and pediatricians.
washingtonpost.com

Lab study shows omicron-blocking antibodies persist four months ......

The study suggests a second booster may not yet be necessary.
washingtonpost.com

FDA authorizes Merck’s anti-coronavirus pill, a second at-home trea...

Merck’s anti-covid pill, molnupiravir, was authorized by federal regulators a day after Pfizer’s pill received a green light. Molnupiravir carries risks, but with treatments in short supply, it may be the only option available.